Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Tesch

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Cancers|February 15, 2022
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto TrialBernd Gerber, Andreas Schneeweiss, Volker Möbus, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and PreventionAndreas Schneeweiss, Michael P Lux, Wolfgang Janni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapyJenny Furlanetto, Volker Möbus, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 4 - Prevention and Early StagesChristoph Thomssen, Tanja N Fehm, Elmar Stickeler, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Archives of Gynecology and Obstetrics|March 24, 2017
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study networkCarlo Fremd, Carolin C Hack, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and BiomarkersFlorin-Andrei Taran, Andreas Schneeweiss, Michael P Lux, et al.
Geburtshilfe Und Frauenheilkunde|September 16, 2022
Update Breast Cancer 2022 Part 3 - Early-Stage Breast CancerTanja N Fehm, Manfred Welslau, Volkmar Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5Markus Sieber, Hans Tesch, Beate Pfistner, et al.
Geburtshilfe Und Frauenheilkunde|March 13, 2023
Update Breast Cancer 2022 Part 6 - Advanced-Stage Breast CancerDiana Lüftner, Michael P Lux, Tanja N Fehm, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Cancers|February 15, 2022
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto TrialBernd Gerber, Andreas Schneeweiss, Volker Möbus, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and PreventionAndreas Schneeweiss, Michael P Lux, Wolfgang Janni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapyJenny Furlanetto, Volker Möbus, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 4 - Prevention and Early StagesChristoph Thomssen, Tanja N Fehm, Elmar Stickeler, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Archives of Gynecology and Obstetrics|March 24, 2017
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study networkCarlo Fremd, Carolin C Hack, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and BiomarkersFlorin-Andrei Taran, Andreas Schneeweiss, Michael P Lux, et al.
Geburtshilfe Und Frauenheilkunde|September 16, 2022
Update Breast Cancer 2022 Part 3 - Early-Stage Breast CancerTanja N Fehm, Manfred Welslau, Volkmar Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5Markus Sieber, Hans Tesch, Beate Pfistner, et al.
Geburtshilfe Und Frauenheilkunde|March 13, 2023
Update Breast Cancer 2022 Part 6 - Advanced-Stage Breast CancerDiana Lüftner, Michael P Lux, Tanja N Fehm, et al.
Pageof 18